All Stories

  1. Emerging safety issues in alemtuzumab-treated MS patients

    Article • Multiple Sclerosis Journal, August 2019, SAGE Publications

    Dr Joep Killestein

  2. CSF examination still has value in the diagnosis of MS – NO

    Article • Multiple Sclerosis Journal, April 2016, SAGE Publications

    Dr Joep Killestein

  3. Low JC virus antibody index during natalizumab treatment less safe than assumed?

    Article • Multiple Sclerosis Journal, October 2015, SAGE Publications

    Dr Joep Killestein